Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05384587 |
|---|---|
| Brief Title: | Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia (ASC2ESCALATE) |
| First Submitted : | May 17, 2022 |
| First Submitted that Met QC Criteria : | May 17, 2022 |
| First Posted : | May 20, 2022 |
| Last Update Submitted that Met QC Criteria : | April 20, 2024 |
| Last Update Posted : | April 23, 2024 |